Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

EMN 2018 | Curing multiple myeloma: have we done it?

Despite the constant research and drug development going on in the field of multiple myeloma (MM), a cure is still out of our reach. Speaking from the 1st European Myeloma Network (EMN) Meeting 2018, in Turin, Italy, Robert Kyle, MD, from the Mayo Clinic, Rochester, MN, explains how although treatments such as stem cell transplantation and combination therapy are quite effective, they are unable to truly eradicate the disease. However, Prof. Kyle concludes his interview by referring to the small percentage of patients who do manage to outlive the disease and hopes that these patients may be the first to be referred to as ‘cured’.